Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of an Anticancer Drug 6-Mercaptopurine

By Gopal Nayak1, Mahendra Kumar Trivedi1, Alice Branton1, Dahryn Trivedi1, Snehasis Jana2

1. Trivedi Global Inc. 2. Trivedi Science Research Laboratory Pvt. Ltd.

Published on

Abstract

Mercaptopurine is an antineoplastic chemotherapy drug is used for the treatment of cancer, Crohn's disease, ulcerative colitis, autoimmune diseases, etc. In this scientific study, the impact of the Trivedi Effect®-Consciousness Energy Healing Treatment on the physicochemical and thermal properties of 6-mercaptopurine was evaluated using the modern analytical technique. The test sample 6-Mercaptopurine powder was divided and named into control and treated sample. The control sample did not receive the Biofield Energy Treatment; whereas, the treated sample received the Biofield Energy Treatment remotely by a well-known Biofield Energy Healer, Gopal Nayak. The particle size values in the treated 6-mercaptopurine sample were significantly decreased by 10.18% (d10), 10.59% (d50), 7.62% (d90), and 9.17% {D(4,3)}; thus, the specific surface area was significantly increased by 10.28% compared to the control sample. The powder XRD peak intensities and crystallite sizes of the treated 6-mercaptopurine were significantly altered ranging from -43.40% to 23.33% and -37.09% to 136.67%, respectively; whereas the average crystallite size was significantly decreased by 11.04% compared with the control sample. The latent heat of evaporation and latent heat of fusion of the treated 6-mercaptopurine were significantly increased by 11.81% and 14.97% compared with the control sample. The total residue amount was significantly increased by 6.44% in the treated sample compared with the control sample. The maximum thermal degradation temperature of the 1st, 2nd, and 3rd peaks of the treated sample was altered by 1.55%, 0.18%, and -1.29% compared with the control sample. It was concluded that the Trivedi Effect®-Consciousness Energy Healing Treatment might have generated a new polymorphic form of 6-mercaptopurine which would offer better solubility, absorption, and bioavailability compared with the control sample. The Biofield Energy Treated 6-mercaptopurine would be more efficacious against acute lymphocytic leukemia, chronic myeloid leukemia, Crohn's disease, ulcerative colitis, and autoimmune diseases.

References

1. Maese L, Raetz, E (2018) Simplifying 6-MP Delivery. The Hematologist: Ash News and Reports 15(1): 11-12.

2. Korelitz BI (2013) Expert opinion: Experience with 6-mercaptopurine in the treatment of inflammatory bowel disease. World J Gastroenterol 19(20): 2979-2984.

3. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, et al. (1980) Treatment of Crohn’s disease with 6-mercaptopurine: A long-term, randomized, double-blind study. N Engl J Med 302(18): 981-798.

4. Schmiegelow K, Glomstein A, Kristinsson J, Björk O (1997) Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO). J Pediatr Hematol Oncol 19(2): 102-109.

5. Sack DM, Peppercorn MA (1983) Drug therapy of inflammatory bowel disease. Pharmacotherapy 3(3): 158-176.

6. WHO (2015) WHO Model List of Essential Medicines, 19th List, World Health Organization. April 2015.

7. Timmer A, Patton PH, Chande N, McDonald JWD, MacDonald JK (2016) Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 5: CD000478.

8. Yang JJ, Landier W, Yang W, Liu C, Hageman L, et al. (2015) Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol 33(11): 1235-1242.

9. Moriyama T, Nishii R, Perez-Andreu V, Yang W, Klussmann FA, et al. (2016) NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nature Genet 48(4): 367-373.

10. Lerner EI, Flashner-Barak M, Achthoven EV, Keegstra H, Smit R (2012) Formulations of 6-mercaptopurine. US patent US8188067B2.

11. Tiphaine Ade B, Hjalgrim LL, Nersting J, Breitkreutz J, Nelken B, et al. (2016) Evaluation of a pediatric liquid formulation to improve 6-mercaptopurine therapy in children. Eur J Pharm Sci 83: 1-7.

12. Xu LL, Chen JM, Yan Y, Lu TB (2012) Improving the Solubility of 6-Mercaptopurine via cocrystals and salts. Cryst Growth Des 12: 6004–6011.

13. Chereson R (2009) Bioavailability, bioequivalence, and drug selection. In: Makoid CM, et al. (Eds.), Basic pharmacokinetics 1st (Edn.), Pharmaceutical Press, London.

14. Nayak G, Trivedi MK, Branton A, Trivedi D, Jana S (2018) Impact of Consciousness energy healing treatment on the physicochemical and thermal properties of vitamin D3 (cholecalciferol). Food Sci Nutr Technol 3(5): 000162.

15. Nayak G, Trivedi MK, Branton A, Trivedi D, Jana S (2018) Evaluation of the consciousness energy healing treated berberine chloride using PXRD, PSA, and DSC Analysis. Food Sci Nutr Technol 3(6): 000168.

16. Branton A, Jana S (2017) Effect of The biofield energy healing treatment on the pharmacokinetics of 25-hydroxyvitamin D3 [25(OH)D3] in rats after a single oral dose of vitamin D3. American Journal of Pharmacology and Phytotherapy 2(1): 11-18.

17. Trivedi MK, Branton A, Trivedi D, Nayak G, Lee AC, et al. (2017) An investigation of The Trivedi Effect®-Energy of Consciousness Healing Treatment to modulate the immunomodulatory effect of herbomineral formulation in male Sprague Dawley rats. American Journal of Biomedical and Life Sciences 5(6): 144-153.

18. Trivedi MK, Mohan TRR (2016) Biofield energy signals, energy transmission and neutrinos. American Journal of Modern Physics 5(6): 172-176.

19. Koithan M (2009) Introducing complementary and alternative therapies. J Nurse Pract 5(1): 18-20.

20. Rubik B (2002) The biofield hypothesis: Its biophysical basis and role in medicine. J Altern Complement Med 8(6): 703-717.

21. Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 12

22. Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, et al. (2012) Use and acceptance of complementary and alternative medicine among the general population and medical personnel: A systematic review. Ochsner J 12(1): 45-56.

23. Trivedi MK, Tallapragada RM (2008) A transcendental to changing metal powder characteristics. Met Powder Rep 63(9): 22-28, 31.

24. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O (2015) Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after bio field treatment. Ind Eng Manage 4: 161.

25. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Mishra R (2015) Influence of biofield treatment on physicochemical properties of hydroxyethyl cellulose and hydroxypropyl cellulose. J Mol Pharm Org Process Res 3: 126.

26. Trivedi MK, Branton A, Trivedi D, Nayak G, Sethi KK, et al. (2016) Gas chromatography-mass spectrometry based isotopic abundance ratio analysis of biofield energy treated methyl-2-napthylether (Nerolin). American Journal of Physical Chemistry 5(4): 80-86.

27. Trivedi MK, Branton A, Trivedi D, Nayak G, Panda P, et al. (2016) Isotopic abundance ratio analysis of 1,2,3-trimethoxybenzene (TMB) after biofield energy treatment (the Trivedi Effect®) using gas chromatography-mass spectrometry. American Journal of Applied Chemistry 4(4): 132-140.

28. Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015) Antibiogram of multidrug-resistant isolates of Pseudomonas aeruginosa after biofield treatment. J Infect Dis Ther 3: 244.

29. Trivedi MK, Branton A, Trivedi D, Shettigar H, Nayak G, et al. (2015) Assessment of antibiogram of multidrug-resistant isolates of Enterobacter aerogenes after biofield energy treatment. J Pharma Care Health Sys 2: 145.

30. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) The potential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy. J Integr Oncol 4: 141.

31. Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, et al. (2015) Effect of biofield energy treatment on chlorophyll content, pathological study, and molecular analysis of cashew plant (Anacardium occidentale L.). Journal of Plant Sciences. 3(6): 372-382.

32. Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Evaluation of plant growth, yield and yield attributes of biofield energy treated mustard (Brassica juncea) and chick pea (Cicer arietinum) seeds. Agriculture, Forestry and Fisheries 4: 291-295.

33. Branton A, Trivedi MK, Trivedi D, Nayak G (2018) Evaluation of the physicochemical and thermal properties of the biofield energy healing treated ofloxacin. J Pharm Pharmaceutics 5: 80-87.

34. Nayak G, Trivedi MK, Branton A, Trivedi D, Jana S (2018) The energy of consciousness healing treatment: Impact on physicochemical and thermal properties of l-tryptophan. Journal of Food Science and Technology 5: 084-094.

35. (1997) Desktop X-ray Diffractometer “MiniFlex+”. The Rigaku Journal 14: 29-36.

36. Zhang T, Paluch K, Scalabrino G, Frankish N, Healy AM, et al. (2015) Molecular structure studies of (1S,2S)-2-benzyl-2,3-dihydro-2-(1Hinden-2-yl)-1H-inden-1-ol. J Mol Struct 1083: 286-299.

37. Langford JI, Wilson AJC (1978) Scherrer after sixty years: A survey and some new results in the determination of crystallite size. J Appl Cryst 11: 102-113.

38. Chereson R (2009) Bioavailability, bioequivalence, and drug selection. In: Makoid CM, et al. (Eds.), Basic pharmacokinetics 1st (Edn.), Pharmaceutical Press, London.

39. Khadka P, Ro J, Kim H, Kim I, Kim JT, et al. (2014) Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 9(6): 304-316.

40. Raza K, Kumar P, Ratan S, Malik R, Arora S (2014) Polymorphism: The phenomenon affecting the performance of drugs. SOJ Pharm Pharm Sci 1(2): 10.

41. Brittain HG (2009) Polymorphism in pharmaceutical solids in Drugs and Pharmaceutical Sciences, 2nd (Edn.), Informa Healthcare USA, Inc., New York.

42. Censi R, Martino PD (2015) Polymorph Impact on the bioavailability and stability of poorly soluble drugs. Molecules 20(10): 18759-18776.

43. Blagden N, de Matas M, Gavan PT, York P (2007) Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 59(7): 617-630.

44. Lv X, Zhao M, Wang Y, Hu X, Wu J, et al. (2016) Loading cisplatin onto 6-mercaptopurine covalently modified MSNS: A nanomedicine strategy to improve the outcome of cisplatin therapy. Dovepress 10: 3933-3946.

45. Zhao Z, Xie M, Li Y, Chen A, Li G, et al. (2015) Formation of curcumin nanoparticles via solution-enhanced dispersion by supercritical CO2. Int J Nanomedicine 10: 3171-3181.

Cite this work

Researchers should cite this work as follows:

  • Nayak G, et al. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of an Anticancer Drug 6-Mercaptopurine. J Cancer Oncol 2019, 3(1): 000137. 
     

  • Gopal Nayak; Mahendra Kumar Trivedi; Alice Branton; Dahryn Trivedi; Snehasis Jana (2019), "Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of an Anticancer Drug 6-Mercaptopurine," https://diagrid.org/resources/1921.

    BibTex | EndNote

Tags